These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18243038)

  • 1. Fibrotic disorders in the eye: targets of gene therapy.
    Saika S; Yamanaka O; Sumioka T; Miyamoto T; Miyazaki K; Okada Y; Kitano A; Shirai K; Tanaka S; Ikeda K
    Prog Retin Eye Res; 2008 Mar; 27(2):177-96. PubMed ID: 18243038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta signal transduction: a potential target for maintenance/restoration of transparency of the cornea.
    Saika S; Yamanaka O; Sumioka T; Okada Y; Miyamoto T; Shirai K; Kitano A; Tanaka S
    Eye Contact Lens; 2010 Sep; 36(5):286-9. PubMed ID: 20823707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Smad signaling by non-TGFβ components in myofibroblast generation during wound healing in corneal stroma.
    Saika S; Yamanaka O; Okada Y; Sumioka T
    Exp Eye Res; 2016 Jan; 142():40-8. PubMed ID: 26675402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF beta in fibroproliferative diseases in the eye.
    Saika S; Yamanaka O; Okada Y; Tanaka S; Miyamoto T; Sumioka T; Kitano A; Shirai K; Ikeda K
    Front Biosci (Schol Ed); 2009 Jun; 1(1):376-90. PubMed ID: 19482708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition as a therapeutic target for prevention of ocular tissue fibrosis.
    Saika S; Yamanaka O; Flanders KC; Okada Y; Miyamoto T; Sumioka T; Shirai K; Kitano A; Miyazaki K; Tanaka S; Ikeda K
    Endocr Metab Immune Disord Drug Targets; 2008 Mar; 8(1):69-76. PubMed ID: 18393925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts.
    Artaza JN; Singh R; Ferrini MG; Braga M; Tsao J; Gonzalez-Cadavid NF
    J Endocrinol; 2008 Feb; 196(2):235-49. PubMed ID: 18252947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue fibrosis and carcinogenesis: divergent or successive pathways dictate multiple molecular therapeutic targets for oligo decoy therapies.
    Cutroneo KR; White SL; Chiu JF; Ehrlich HP
    J Cell Biochem; 2006 Apr; 97(6):1161-74. PubMed ID: 16408276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term exposure to transforming growth factor beta induces long-term fibrotic responses.
    Wormstone IM; Anderson IK; Eldred JA; Dawes LJ; Duncan G
    Exp Eye Res; 2006 Nov; 83(5):1238-45. PubMed ID: 16934251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of anti-fibrotic signaling by hepatocyte growth factor in renal fibroblasts.
    Schievenbusch S; Strack I; Scheffler M; Wennhold K; Maurer J; Nischt R; Dienes HP; Odenthal M
    Biochem Biophys Res Commun; 2009 Jul; 385(1):55-61. PubMed ID: 19426716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
    Guarino M; Tosoni A; Nebuloni M
    Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?
    Abraham D
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v8-9. PubMed ID: 18784153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrosis in the anterior segments of the eye.
    Yamanaka O; Liu CY; Kao WW
    Endocr Metab Immune Disord Drug Targets; 2010 Dec; 10(4):331-5. PubMed ID: 20925651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of trichostatin A to control inflammatory and fibrogenic disorders of the ocular surface.
    Kitano A; Okada Y; Yamanka O; Shirai K; Mohan RR; Saika S
    Mol Vis; 2010 Dec; 16():2964-73. PubMed ID: 21203344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroproliferative disorders and their mechanobiology.
    Huang C; Ogawa R
    Connect Tissue Res; 2012; 53(3):187-96. PubMed ID: 22329637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gene therapy in ophthalmology. Review of options and trends in corneal diseases].
    Pleyer U; Dannowski H; Reszka R; Volk HD; Hartmann C; Ritter T
    Klin Monbl Augenheilkd; 2001 Mar; 218(3):140-7. PubMed ID: 11322050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of matrix turnover: fibroblasts, forces, factors and fibrosis.
    Laurent GJ; Chambers RC; Hill MR; McAnulty RJ
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):647-51. PubMed ID: 17635112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats.
    Camino AM; Atorrasagasti C; Maccio D; Prada F; Salvatierra E; Rizzo M; Alaniz L; Aquino JB; Podhajcer OL; Silva M; Mazzolini G
    J Gene Med; 2008 Sep; 10(9):993-1004. PubMed ID: 18615449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crucial role of fibrogenesis in pancreatic diseases.
    Jaster R; Emmrich J
    Best Pract Res Clin Gastroenterol; 2008; 22(1):17-29. PubMed ID: 18206810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases.
    Gressner OA; Gressner AM
    Liver Int; 2008 Sep; 28(8):1065-79. PubMed ID: 18783549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of TGF-beta isoforms and signaling intermediates in corneal fibrotic wound repair.
    Huh MI; Kim YH; Park JH; Bae SW; Kim MH; Chang Y; Kim SJ; Lee SR; Lee YS; Jin EJ; Sonn JK; Kang SS; Jung JC
    J Cell Biochem; 2009 Oct; 108(2):476-88. PubMed ID: 19626665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.